The importance of proteolytic activity within the central nervous system (CNS) in both normal and pathological processes is well established. However, the mechanisms whereby proteinase activity contributes to such complex processes as axonal extension, synaptic remodeling or neuronal survival are not known. Many different proteinases and their inhibitors are known to be expressed in both the developing and the adult CNS. These include members of the serine proteinase family and their inhibitors. This application examines the biology of one recently identified serine proteinase inhibitors, neuroserpin. Neuroserpin is a member of serpin gene family of serine proteinase inhibitors, and inactivates the serine proteinase tissue-type plasminogen activator (tPA). TPA has been implicated in processes that promote neuronal cell death, and is also thought to be involved in events that require neuronal plasticity such as axonal extension, synaptic remodeling, long-term potentiation, kindling and seizure. Accordingly, this proposal will focus on understanding the basic biology of neuroserpin and on its role in promoting neuronal cell survival. By using a combination of biochemical, molecular and genetic approaches both in vitro and in vivo, and building on previous studies of neuroserpin, a number of important interactions will be characterized. We will test the hypotheses that: (1) neuroserpin is expressed in neurons and targeted to a regulated secretion pathway where it is likely to be released at the synapse; (2) in vivo, neuroserpin's primary function is to regulate tPA activity; and (3) neuroserpin is a potent neuroprotectant increasing neuronal survival after insults such as stroke or seizure. Sensitive assays will be developed to localize neuroserpin and tPA within the cell and to characterize their trafficking. Finally, animal models will be used to examine the role of neuroserpin and tPA in pathologies associated with both stroke and seizure, and the potential therapeutic benefit of neuroserpin administration will be tested.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055374-07
Application #
6537230
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Link, Rebecca P
Project Start
1995-08-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
7
Fiscal Year
2002
Total Cost
$269,850
Indirect Cost
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Waack, Ursula; Warnock, Mark; Yee, Andrew et al. (2018) CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII. MBio 9:
Bondu, Virginie; Bitting, Casey; Poland, Valerie L et al. (2018) Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome. Front Cell Infect Microbiol 8:169
Wahlgren, N; Thorén, M; Höjeberg, B et al. (2017) Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis. J Intern Med 281:273-283
Bohannon, Kevin P; Bittner, Mary A; Lawrence, Daniel A et al. (2017) Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo. J Gen Physiol 149:921-934
Su, Enming Joseph; Cao, Chunzhang; Fredriksson, Linda et al. (2017) Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Acta Neuropathol 134:585-604
Fredriksson, Linda; Lawrence, Daniel A; Medcalf, Robert L (2017) tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS. Semin Thromb Hemost 43:154-168
Carlson, Karen-Sue B; Nguyen, Lan; Schwartz, Kat et al. (2016) Neuroserpin Differentiates Between Forms of Tissue Type Plasminogen Activator via pH Dependent Deacylation. Front Cell Neurosci 10:154
Lewandowski, Sebastian A; Fredriksson, Linda; Lawrence, Daniel A et al. (2016) Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders. Pharmacol Ther 167:108-119
Medcalf, Robert L; Lawrence, Daniel A (2016) Editorial: The Role of the Plasminogen Activating System in Neurobiology. Front Cell Neurosci 10:222
Szabo, R; Samson, A L; Lawrence, D A et al. (2016) Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains. J Thromb Haemost 14:1618-28

Showing the most recent 10 out of 70 publications